Back to funds
View filing
B Group, Inc.
hedge fundUpdated 28 days agoManaged by B Group, Inc. • Latest filing Q2 2026
Portfolio value
$213M
Q2 2026
Filings
7
Quarterly 13F history
Top-10 concentration
82.7%
Weight of largest holdings
Annualized return
-17.2%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 7 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2024 | $163.6M |
| Q1 2025 | $116.7M |
| Q2 2025 | $129.9M |
| Q3 2025 | $135.9M |
| Q4 2025 | $135.4M |
| Q1 2026 | $134.9M |
| Q2 2026 | $213M |
Top holdings
19 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | ? N/A INVESCO QQQ TR | $36.8M | 50.0K | 17.29% | — |
| 2 | A ADMA ADMA BIOLOGICS INC | $27.3M | 3.26M | 12.82% | — |
| 3 | ? N/A PALISADE BIO INC | $23.9M | 11.41M | 11.20% | — |
| 4 | ? N/A NRX PHARMACEUTICALS INC | $16.7M | 4.09M | 7.86% | — |
| 5 | F FTH FAETH THERAPEUTICS INC | $15.3M | 610.2K | 7.16% | — |
| 6 | T TSHA TAYSHA GENE THERAPIES INC | $12.3M | 1.80M | 5.76% | — |
| 7 | P PRAX PRAXIS PRECISION MEDICINES I | $11.1M | 33.2K | 5.22% | — |
| 8 | C CLLS CELLECTIS S A | $9.8M | 3.28M | 4.62% | — |
| 9 | Z ZLAB ZAI LAB LTD | $8.6M | 450.6K | 4.02% | — |
| 10 | G GPCR STRUCTURE THERAPEUTICS INC | $7.5M | 140.0K | 3.53% | — |
| 11 | O ORKA ORUKA THERAPEUTICS INC | $7.1M | 75.0K | 3.35% | — |
| 12 | J JPM-PM IOVANCE BIOTHERAPEUTICS INC | $6.2M | 1.50M | 2.93% | — |
| 13 | S SYRE SPYRE THERAPEUTICS INC | $6.2M | 70.0K | 2.92% | — |
| 14 | A AURA AURA BIOSCIENCES INC | $5.4M | 764.2K | 2.55% | — |
| 15 | A ASH ASSEMBLY BIOSCIENCES INC | $4.8M | 175.7K | 2.27% | — |
| 16 | D DRUG BRIGHT MINDS BIOSCIENCES INC | $4.7M | 67.5K | 2.22% | — |
| 17 | R RARE ULTRAGENYX PHARMACEUTICAL IN | $4.5M | 135.0K | 2.12% | — |
| 18 | B BSRR SIGHT SCIENCES INC | $3.7M | 970.0K | 1.72% | — |
| 19 | F FHTX FOGHORN THERAPEUTICS INC | $976K | 200.0K | 0.46% | — |